Motorola Solutions Inc vs Revvity Inc — how do they compare? Motorola Solutions Inc trades at $443.73 (market cap $74.00B), while Revvity Inc trades at $154.86 (market cap $16.98B). The key difference: Motorola Solutions Inc is far larger — about 4.4× Revvity Inc's market cap, and Motorola Solutions Inc pays the higher dividend (1.08%). Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 100 Days and Revvity Inc for 12 Days on average.
| MSI | RVTY | |
|---|---|---|
Market Cap | $74.00B | $16.98B |
Volume | 722,147 | 1,456,900 |
Sector | Technology | Health |
52-Week High | $491.24 | $157.36 |
52-Week Low | $363.83 | $82.26 |
Typical Hold Time | 100 Days | 12 Days |
Enterprise Value | $82.90B | $19.30B |
Dividend Yield | 1.08% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $443.80, down 1.04% on the day, with a bearish technical signal from moving averages. The company shows strong fundamentals with revenue growth to $11.68B in 2025 and net income of $2.15B, supported by a record $15.6B backlog as of Q2 2026 (Zacks Investment Research, 2026-09-28). Recent acquisitions like D-Fend Solutions for $1.5B expand its security portfolio, while a new $2B share repurchase authorization signals confidence (Business Wire, 2026-09-09).
The outlook is positive with a consensus price target of $525.86, implying 18.5% upside, and 71% of analysts rate it a Buy. Risks include elevated debt levels with a debt-to-asset ratio of 47.29% in 2025 and negative net cash flow trends, but strong public safety contract wins and AI integration in video analytics provide growth catalysts.
Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.
The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.
Trailing returns across standard periods
Latest headlines on both assets
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →